BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 22158946)

  • 1. Targeting protein synthesis in a Myc/mTOR-driven model of anorexia-cachexia syndrome delays its onset and prolongs survival.
    Robert F; Mills JR; Agenor A; Wang D; DiMarco S; Cencic R; Tremblay ML; Gallouzi IE; Hekimi S; Wing SS; Pelletier J
    Cancer Res; 2012 Feb; 72(3):747-56. PubMed ID: 22158946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The glucocorticoid receptor is increased in Atm-/- thymocytes and in Atm-/- thymic lymphoma cells, and its nuclear translocation counteracts c-myc expression.
    Yan M; Kuang X; Scofield VL; Shen J; Lynn WS; Wong PK
    Steroids; 2007 May; 72(5):415-21. PubMed ID: 17418878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of adenocarcinoma colon 26-induced cachexia by interleukin 10 gene transfer.
    Fujiki F; Mukaida N; Hirose K; Ishida H; Harada A; Ohno S; Bluethmann H; Kawakami M; Akiyama M; Sone S; Matsushima K
    Cancer Res; 1997 Jan; 57(1):94-9. PubMed ID: 8988047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central infusion of the melanocortin receptor antagonist agouti-related peptide (AgRP(83-132)) prevents cachexia-related symptoms induced by radiation and colon-26 tumors in mice.
    Joppa MA; Gogas KR; Foster AC; Markison S
    Peptides; 2007 Mar; 28(3):636-42. PubMed ID: 17204351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of cytokines in cancer cachexia in a murine model of intracerebral injection of human tumours.
    Negri DR; Mezzanzanica D; Sacco S; Gadina M; Benigni F; Cajola L; Finocchiaro G; Ghezzi P; Canevari S
    Cytokine; 2001 Jul; 15(1):27-38. PubMed ID: 11509006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of cancer cachexia by a novel nuclear factor {kappa}B inhibitor in prostate cancer.
    Kuroda K; Horiguchi Y; Nakashima J; Kikuchi E; Kanao K; Miyajima A; Ohigashi T; Umezawa K; Murai M
    Clin Cancer Res; 2005 Aug; 11(15):5590-4. PubMed ID: 16061877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aerobic and resistance training dependent skeletal muscle plasticity in the colon-26 murine model of cancer cachexia.
    Khamoui AV; Park BS; Kim DH; Yeh MC; Oh SL; Elam ML; Jo E; Arjmandi BH; Salazar G; Grant SC; Contreras RJ; Lee WJ; Kim JS
    Metabolism; 2016 May; 65(5):685-698. PubMed ID: 27085776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibiting the mTOR pathway synergistically enhances cytotoxicity in ovarian cancer cells induced by etoposide through upregulation of c-Jun.
    Itamochi H; Oishi T; Shimada M; Sato S; Uegaki K; Naniwa J; Sato S; Nonaka M; Terakawa N; Kigawa J; Harada T
    Clin Cancer Res; 2011 Jul; 17(14):4742-50. PubMed ID: 21610153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletion of the gene encoding MyD88 protects from anorexia in a mouse tumor model.
    Ruud J; Bäckhed F; Engblom D; Blomqvist A
    Brain Behav Immun; 2010 May; 24(4):554-7. PubMed ID: 20093176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2-Arylthiazolidine-4-carboxylic acid amides (ATCAA) target dual pathways in cancer cells: 5'-AMP-activated protein kinase (AMPK)/mTOR and PI3K/Akt/mTOR pathways.
    Li CM; Narayanan R; Lu Y; Hurh E; Coss CC; Barrett CM; Miller DD; Dalton JT
    Int J Oncol; 2010 Oct; 37(4):1023-30. PubMed ID: 20811725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ActRII blockade protects mice from cancer cachexia and prolongs survival in the presence of anti-cancer treatments.
    Hatakeyama S; Summermatter S; Jourdain M; Melly S; Minetti GC; Lach-Trifilieff E
    Skelet Muscle; 2016; 6():26. PubMed ID: 27462398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anorexia and cachexia in prostaglandin EP1 and EP3 subtype receptor knockout mice bearing a tumor with high intrinsic PGE2 production and prostaglandin related cachexia.
    Wang W; Andersson M; Lönnroth C; Svanberg E; Lundholm K
    J Exp Clin Cancer Res; 2005 Mar; 24(1):99-107. PubMed ID: 15943039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental cancer cachexia: the role of host-derived cytokines interleukin (IL)-6, IL-12, interferon-gamma, and tumor necrosis factor alpha evaluated in gene knockout, tumor-bearing mice on C57 Bl background and eicosanoid-dependent cachexia.
    Cahlin C; Körner A; Axelsson H; Wang W; Lundholm K; Svanberg E
    Cancer Res; 2000 Oct; 60(19):5488-93. PubMed ID: 11034092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intratumoral injection of oligonucleotides to the NF kappa B binding site inhibits cachexia in a mouse tumor model.
    Kawamura I; Morishita R; Tomita N; Lacey E; Aketa M; Tsujimoto S; Manda T; Tomoi M; Kida I; Higaki J; Kaneda Y; Shimomura K; Ogihara T
    Gene Ther; 1999 Jan; 6(1):91-7. PubMed ID: 10341880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival.
    Zhou X; Wang JL; Lu J; Song Y; Kwak KS; Jiao Q; Rosenfeld R; Chen Q; Boone T; Simonet WS; Lacey DL; Goldberg AL; Han HQ
    Cell; 2010 Aug; 142(4):531-43. PubMed ID: 20723755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-induced anorexia and weight loss are mediated by the TGF-beta superfamily cytokine MIC-1.
    Johnen H; Lin S; Kuffner T; Brown DA; Tsai VW; Bauskin AR; Wu L; Pankhurst G; Jiang L; Junankar S; Hunter M; Fairlie WD; Lee NJ; Enriquez RF; Baldock PA; Corey E; Apple FS; Murakami MM; Lin EJ; Wang C; During MJ; Sainsbury A; Herzog H; Breit SN
    Nat Med; 2007 Nov; 13(11):1333-40. PubMed ID: 17982462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of intermittent and chronic calorie restriction on mammalian target of rapamycin (mTOR) and IGF-I signaling pathways in mammary fat pad tissues and mammary tumors.
    Dogan S; Johannsen AC; Grande JP; Cleary MP
    Nutr Cancer; 2011; 63(3):389-401. PubMed ID: 21462085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of insulin in development of cancer cachexia in nongrowing sarcoma-bearing mice: special reference to muscle wasting.
    Svaninger G; Drott C; Lundholm K
    J Natl Cancer Inst; 1987 May; 78(5):943-50. PubMed ID: 3553691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of altered Toll-like receptor 4 signaling on cancer cachexia.
    Cannon TY; Guttridge D; Dahlman J; George JR; Lai V; Shores C; Buzková P; Couch ME
    Arch Otolaryngol Head Neck Surg; 2007 Dec; 133(12):1263-9. PubMed ID: 18086970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Provision of rhIGF-I/IGFBP-3 complex attenuated development of cancer cachexia in an experimental tumor model.
    Wang W; Iresjö BM; Karlsson L; Svanberg E
    Clin Nutr; 2000 Apr; 19(2):127-32. PubMed ID: 10867731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.